FAM90A10: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A10

Target Name: FAM90A10

NCBI ID: G441328

FAM90A10

Other Name(s): family with sequence similarity 90 member A10 | FAM90A10P | family with sequence similarity 90 member A10, pseudogene | putative protein FAM90A10P | Putative protein FAM90A10

FAM90A10: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A10

The family with sequence similarity (FAM) is a group of proteins that share a high degree of sequence identity. FAM proteins are involved in various cellular processes, including DNA replication, transcription, and repair. The FAM90A10 protein is one of the members of the FAM family that has been identified using bioinformatics analysis. This protein is of particular interest due to its sequence similarity to other FAM proteins and its potential as a drug target or biomarker.

FAM90A10: A Protein of Interest

The FAM90A10 protein is a member of the FAM family that has been identified using the Bioinformatics Analysis of Sequence Datasets (BAS) as having a high degree of sequence similarity to other FAM proteins, including FAM90A20, FAM90A30, and FAM90A40. FAM90A10 is also known as CRM1 and has been shown to play a role in various cellular processes, including the regulation of DNA replication and transcription.

Function and Interaction

FAM90A10 is involved in the regulation of DNA replication, specifically in the process of DNA double-strand break repair. DNA double-strand breaks are a common occurrence in DNA replication and can lead to genetic mutations. FAM90A10 is known to be involved in the repair of these breaks by interacting with the protein NIP (Nucleotide-Induced Proteasome-Driven Enrichment). NIP is a protein that is involved in the regulation of DNA replication and is composed of multiple domains, including a nucleotide-binding domain, a catalytic domain, and a regulatory domain.

FAM90A10 has also been shown to interact with the protein HDAC (Histone Degradation-Induced Chk1-Activated Kinesin), which is involved in the regulation of DNA replication and histone degradation. HDAC is a protein that is composed of multiple domains, including a nucleotide-binding domain, a catalytic domain, and a regulatory domain.

Drug Target Potential

FAM90A10 is a protein that is involved in various cellular processes, including the regulation of DNA replication and transcription. As such, it is a potential drug target. The use of drugs that target specific proteins, such as FAM90A10, can be an effective way to treat diseases caused by the over-expression or deletion of specific genes.

FAM90A10 has been shown to interact with various drug targets, including the protein PDCD1 (Protamineuronic Acid-Catalyzed DNA Glycosylationase 1) and the protein HDAC2 (Histone Degradation-Induced Chk1-Activated Kinesin 2). These drug targets are of particular interest due to their involvement in the regulation of DNA replication and transcription, which is the target of the FAM90A10 protein.

Biomarker Potential

FAM90A10 is also a potential biomarker for various diseases. The over-expression or deletion of FAM90A10 can lead to the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. As such, FAM90A10 may be used as a biomarker for the diagnosis and treatment of these diseases.

Conclusion

FAM90A10 is a protein of interest that has been shown to interact with various drug targets and participate in the regulation of various cellular processes. Its potential as a drug target or biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of FAM90A10 in

Protein Name: Family With Sequence Similarity 90 Member A10

The "FAM90A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM90A10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets